The rate of the eye problem known as nonarteritic anterior ischemic optic neuropathy, or NAION, was 8.9% for those taking semaglutide for type 2 diabetes, compared with 1.8% for patients taking non-GLP-1 diabetes medications, researchers reported in JAMA Ophthalmology
It is important not to exclude a diagnosis of malignancy solely on a history of trauma, as many patients with a subungual melanoma will recall an injury to the digit
Your provider can help determine the safest and most appropriate approach
Tirzepatide and combination therapies range $289/mo month-to-month, or from $249/mo on the 6-month plan to monthly depending on formulation
But heres the critical point our team can't stress enough: GLP-3, as a distinct, identified hormone, remains elusive and unproven